Medicare Enrolled
Dr. Monty Aghazadeh, MD
Urology Physician · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Aghazadeh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aghazadeh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aghazadeh
Dr. Monty Aghazadeh is an urology physician in Houston, TX, with 15 years of NPI registration. Based on federal Medicare data, Dr. Aghazadeh performed 1,149 Medicare services across 1,001 unique beneficiaries.
Between the years covered by Open Payments, Dr. Aghazadeh received a total of $33,570 from 51 pharmaceutical and/or device companies across 235 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aghazadeh is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ 1,149 Medicare services
$33,570 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,149
Medicare services
Bottom 38% in TX for urology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
1,001
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~77 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
267 | $93 | $314 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
155 | $8 | $112 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
132 | $116 | $483 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
75 | $184 | $1,081 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
72 | $62 | $212 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
63 | $96 | $401 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
45 | $89 | $302 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
41 | $19 | $663 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
29 | $288 | $3,886 |
| Endoscopic removal of pelvic lymph nodes, bilateral A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue. |
28 | $76 | $1,790 |
| Suture suspension of urethra to control leakage using an endoscope A surgical procedure that uses an endoscope to place sutures that suspend the urethra in order to control urinary leakage. |
27 | $89 | $1,678 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
26 | $6 | $442 |
| Nerve repair with graft A surgical procedure to repair a damaged nerve by using a graft to bridge the gap between the severed ends. |
25 | $84 | $1,710 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $46 | $128 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
22 | $63 | $175 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
20 | $112 | $857 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
20 | $312 | $2,026 |
| Laparoscopic partial prostate removal A minimally invasive surgical procedure to remove part of the prostate gland using a laparoscope. |
19 | $504 | $3,518 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
13 | $104 | $498 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $126 | $421 |
| Complex kidney stone removal with imaging guidance A surgical procedure to remove kidney stones using imaging technology to guide the process. |
12 | $462 | $4,002 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
12 | $94 | $255 |
| Partial kidney removal using endoscope Surgical removal of part of the kidney through a small incision using an endoscope. This minimally invasive technique allows for targeted tissue removal without large open incisions. |
11 | $563 | $4,866 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.5% high complexity
19.2% medium
77.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$33,570
Total received (2018-2024)
Avg $4,796/year across 7 years
Top 8% in TX for urology physician
51
Companies
235
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$25,872 (77.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,698 (22.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$15,949
2023
$11,330
2022
$1,781
2021
$484
2020
$462
2019
$2,117
2018
$1,448
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$15,223
Intuitive Surgical, Inc.
$10,793
Boston Scientific Corporation
$1,856
Coloplast Corp
$1,253
KARL STORZ Endoscopy-America
$1,065
Endo Pharmaceuticals Inc.
$387
PROCEPT BioRobotics Corporation
$316
PFIZER INC.
$300
Astellas Pharma US Inc
$273
Janssen Biotech, Inc.
$188
COLOPLAST CORP
$176
Myriad Genetic Laboratories, Inc.
$156
Merck Sharp & Dohme LLC
$134
NeoTract Inc.
$117
ConvaTec Inc.
$113
Antares Pharma, Inc.
$101
180 Medical, Inc.
$77
Dendreon Pharmaceuticals LLC
$77
Ethicon US, LLC
$60
Egalet US Inc
$60
Ferring Pharmaceuticals Inc.
$58
Teleflex LLC
$58
Axonics, Inc.
$57
ABC Home Medical Supply, Inc.
$54
Endo USA, Inc.
$46
Blue Earth Diagnostics Limited
$43
AbbVie, Inc.
$38
NxThera, Inc.
$30
Olympus America Inc.
$30
BIOTISSUE HOLDINGS INC.
$29
IMMUNITYBIO, INC.
$26
Novo Nordisk Inc
$25
Tolmar, Inc.
$24
Medtronic, Inc.
$23
Sumitomo Pharma America, Inc.
$23
Avadel Specialty Pharmaceuticals, LLC
$22
Amgen Inc.
$22
UROVANT SCIENCES INC
$20
Zyla Life Sciences
$19
Mission Pharmacal Company
$19
Merck Sharp & Dohme Corporation
$19
ABBVIE INC.
$19
UROGEN PHARMA, INC.
$18
AbbVie Inc.
$18
Retrophin, Inc.
$17
Janssen Pharmaceuticals, Inc
$17
Heron Therapeutics, Inc.
$17
Acerus Pharmaceuticals Corporation
$16
BIOTISSUE HOLDINGS, INC.
$13
AKRIMAX PHARMACEUTICALS, LLC
$13
Ambu Inc.
$10
Top 3 companies account for 83.0% of total payments
Associated products mentioned in payments ›
(815) Thiola · 24/26 FR. · 7FR X 34CM · 8.5 FR. X 675MM · ACLAV · ADSTILADRIN · ALTIS · AMS · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AVEED · Altis · Androgel · AquaBeam Robotic System · Axonics · Axumin · BIPOLAR · BRAC CDx · BRACAnalysis CDx · CMOS VIDEO URETEROSCOPE · CUTTING LOOP · CYSTO-URETHRO-FIBERSCOPE · Coloplast TFL Drive · DA VINCI SP · Da Vinci Surgical System · ECHELON ENDOPATH · ELIGARD · ERLEADA · EVICEL · Erleada · FEMALE INCONTINENCE · GEMTESA · GENERAL BPH · GENERAL FEMALE SUI · GENTLECATH · General - BPH · General - Kidney Stone Disease · General - Therapies · Isiris aStent Removal Device · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · Lupron · MYRBETRIQ · Moses 550 DFL · Moses 550 D\F\L · Myrbetriq · NEOX · NEPHROSCOPE MIP M · NOCDURNA · Natesto · Noctiva · ORGOVYX · Olympus Laser Devices · PROLARIS · PROVENGE · Prolaris · Prolia · RESTORELLE · Rezum · Rezum Generator · Rivfloza · SIGNIA · SOLYX · SPRIX · SpeediCath · Stendra · URETERO-RENOSCOPE · UROLIFT · Uribel · UroLift · VESICARE · VISTASEAL Fibrin Sealant (Human) · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYNRELEF · ZYTIGA · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (77%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for urology physician in TX.
Equivalent to $2,922 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
188
Per 100K population
4.0
County median income
$73,104
Nearest hospital
HOUSTON METHODIST WEST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Aghazadeh is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 8% of TX peers, with 15 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Aghazadeh experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Aghazadeh performed 267 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aghazadeh receive payments from pharmaceutical companies?
Yes. Dr. Aghazadeh received a total of $33,570 from 51 companies across 235 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aghazadeh's costs compare to other urology physicians in Houston?
Dr. Aghazadeh's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aghazadeh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Houston
Browse urology physicians in Houston ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology